Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in BMJ Retrieve available abstracts of 97 articles: HTML format

Single Articles

May 2024
1. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
   Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
   BMJ. 2024;385:e077097.
   PubMed     Abstract available
   
   
   April 2024
2. MAHASE E
   Diabetes UK defends partnership with Slimming World in face of criticism.
   BMJ. 2024;385:q962.
   PubMed    
   
   
   
3. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
   Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
   BMJ. 2024;385:e078242.
   PubMed     Abstract available
   
   
   
4. NOLAN T
   The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
   BMJ. 2024;385:q859.
   PubMed    
   
   
   
5. SETHI J
   Breaking free from the stigma of diabetes.
   BMJ. 2024;385:q890.
   PubMed    
   
   
   
6. BOKINNI Y
   Barbados is in the grip of a diabetic foot amputation crisis.
   BMJ. 2024;385:q350.
   PubMed    
   
   
   
7. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
   Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
   BMJ. 2024;385:e078225.
   PubMed     Abstract available
   
   
   March 2024
8. CHRISTIE B
   Charity calls for Scottish government to increase access to diabetes technology.
   BMJ. 2024;384:q755.
   PubMed    
   
   
   
9. MAHASE E
   Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
   BMJ. 2024;384:q744.
   PubMed    
   
   
   
10. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    PubMed     Abstract available
    
    
    
11. TANNE JH
    FDA approves first over-the-counter blood glucose monitor for diabetes.
    BMJ. 2024;384:q611.
    PubMed    
    
    
    
12. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    PubMed    
    
    
    February 2024
13. LANE MM, Gamage E, Du S, Ashtree DN, et al
    Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
    BMJ. 2024;384:e077310.
    PubMed     Abstract available
    
    
    
14. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    PubMed     Abstract available
    
    
    
15. BHALA N
    Liver steatosis linked to type 2 diabetes outcomes.
    BMJ. 2024;384:q309.
    PubMed    
    
    
    January 2024
16. YAO H, Zhang A, Li D, Wu Y, et al
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ. 2024;384:e076410.
    PubMed     Abstract available
    
    
    
17. SUBRAMANIAN S, Khan F, Hirsch IB
    New advances in type 1 diabetes.
    BMJ. 2024;384:e075681.
    PubMed     Abstract available
    
    
    
18. IACOBUCCI G
    Artificial pancreases for type 1 diabetes: Better access is "watershed moment"-but delivery is key.
    BMJ. 2024;384:q102.
    PubMed    
    
    
    
19. IACOBUCCI G
    Fragmented care is failing people with type 1 diabetes related eating disorders, inquiry finds.
    BMJ. 2024;384:q178.
    PubMed    
    
    
    
20. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    PubMed    
    
    
    December 2023
21. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    PubMed     Abstract available
    
    
    
22. COHEN D
    GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm.
    BMJ. 2023;383:2906.
    PubMed    
    
    
    
23. CHEN TK, Hoenig MP, Nitsch D, Grams ME, et al
    Advances in the management of chronic kidney disease.
    BMJ. 2023;383:e074216.
    PubMed     Abstract available
    
    
    November 2023
24. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    PubMed    
    
    
    
25. IACOBUCCI G
    England's diabetes prevention programme has delivered causal benefits, study reports.
    BMJ. 2023;383:p2691.
    PubMed    
    
    
    
26. MAHASE E
    NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes.
    BMJ. 2023;383:p2619.
    PubMed    
    
    
    October 2023
27. KAR P
    Partha Kar: The time to tackle rising type 2 diabetes is T2DaY.
    BMJ. 2023;383:p2490.
    PubMed    
    
    
    
28. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    PubMed     Abstract available
    
    
    
29. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    PubMed     Abstract available
    
    
    September 2023
30. WILL EJ
    SGLT2 inhibitors: here we go again?
    BMJ. 2023;382:2172.
    PubMed    
    
    
    
31. 
    Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    BMJ. 2023;382:p2072.
    PubMed    
    
    
    
32. FOU L, Agwu JC, Aswani N, Bakhai C, et al
    Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2023;382:p1686.
    PubMed    
    
    
    
33. MAHASE E
    Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes.
    BMJ. 2023;382:2074.
    PubMed    
    
    
    
34. IACOBUCCI G
    Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.
    BMJ. 2023;382:2019.
    PubMed    
    
    
    July 2023
35. BRAITHWAITE B
    Risk of diabetes with statins: comparing apples with oranges.
    BMJ. 2023;382:p1720.
    PubMed    
    
    
    
36. IACOBUCCI G
    UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages.
    BMJ. 2023;382:1693.
    PubMed    
    
    
    
37. HANNA F, Wu P, Heald A, Fryer A, et al
    Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome.
    BMJ. 2023;382:e071675.
    PubMed     Abstract available
    
    
    June 2023
38. MAHASE E
    Tackling structural racism is crucial to ending global diabetes crisis, researchers say.
    BMJ. 2023;381:p1439.
    PubMed    
    
    
    
39. WISE J
    Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds.
    BMJ. 2023;381:p1306.
    PubMed    
    
    
    May 2023
40. GRAY M
    Preventing type 2 diabetes: public health campaigns should focus on living longer better.
    BMJ. 2023;381:p1139.
    PubMed    
    
    
    
41. MANSI IA, Sumithran P, Kinaan M
    Risk of diabetes with statins.
    BMJ. 2023;381:e071727.
    PubMed    
    
    
    
42. IACOBUCCI G
    Diabetes: Missed routine checks are causing premature deaths in England, charity warns.
    BMJ. 2023;381:1070.
    PubMed    
    
    
    
43. WHITE SL, Ayman G, Bakhai C, Hillier TA, et al
    Screening and diagnosis of gestational diabetes.
    BMJ. 2023;381:e071920.
    PubMed    
    
    
    April 2023
44. VALABHJI J, Kar P
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p910.
    PubMed    
    
    
    
45. 
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p941.
    PubMed    
    
    
    
46. SAUL H, Deeney B, Imison C, Tesfaye S, et al
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ. 2023;381:p866.
    PubMed     Abstract available
    
    
    
47. MA L, Hu Y, Alperet DJ, Liu G, et al
    Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study.
    BMJ. 2023;381:e073406.
    PubMed     Abstract available
    
    
    
48. FOROUHI NG
    Beverages and health outcomes in adults with type 2 diabetes.
    BMJ. 2023;381:p841.
    PubMed    
    
    
    
49. LYU H, Zhao SS, Zhang L, Wei J, et al
    Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
    BMJ. 2023;381:e073435.
    PubMed     Abstract available
    
    
    
50. WISE J
    Diabetes cases in UK reach all time high, charity warns.
    BMJ. 2023;381:p848.
    PubMed    
    
    
    
51. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    PubMed     Abstract available
    
    
    March 2023
52. MCCARTNEY M
    Semaglutide: should the media slim down its enthusiasm?
    BMJ. 2023;380:p624.
    PubMed    
    
    
    
53. WISE J
    Novo Nordisk suspended from industry body over serious breaches.
    BMJ. 2023;380:p634.
    PubMed    
    
    
    February 2023
54. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    PubMed     Abstract available
    
    
    January 2023
55. IACOBUCCI G
    Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    BMJ. 2023;380:p55.
    PubMed    
    
    
    December 2022
56. XIE J, Wang M, Long Z, Ning H, et al
    Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.
    BMJ. 2022;379:e072385.
    PubMed     Abstract available
    
    
    November 2022
57. TAYLOR L
    Diabetes prevalence in Americas tripled in 30 years.
    BMJ. 2022;379:o2868.
    PubMed    
    
    
    
58. IACOBUCCI G
    Type 1 diabetes: US approves drug that can delay onset.
    BMJ. 2022;379:o2798.
    PubMed    
    
    
    
59. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    PubMed     Abstract available
    
    
    October 2022
60. MULVIHILL C, Brooks A, Basudev N, Lincoln P, et al
    Continuous glucose monitoring for adults and children with diabetes: summary of updated NICE guidance.
    BMJ. 2022;379:o2418.
    PubMed    
    
    
    
61. HUANG C, Wei K, Lee PMY, Qin G, et al
    Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.
    BMJ. 2022;379:e072157.
    PubMed     Abstract available
    
    
    
62. IKOMI AE
    It's time to widen the capture of gestational diabetes in the UK.
    BMJ. 2022;379:o2444.
    PubMed    
    
    
    
63. DENG Y, Polley EC, Wallach JD, Dhruva SS, et al
    Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    BMJ. 2022;379:e070717.
    PubMed     Abstract available
    
    
    September 2022
64. MAHASE E
    Type 1 diabetes: Global prevalence is set to double by 2040, study estimates.
    BMJ. 2022;378:o2289.
    PubMed    
    
    
    
65. YANG J, Qian F, Chavarro JE, Ley SH, et al
    Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study.
    BMJ. 2022;378:e070312.
    PubMed     Abstract available
    
    
    
66. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    PubMed     Abstract available
    
    
    August 2022
67. MARSTON L
    The failed promise of the US's Inflation Reduction Act for patients with diabetes.
    BMJ. 2022;378:o2086.
    PubMed    
    
    
    
68. HUSSAIN Z
    NHS to rollout continuous glucose monitors for all patients with type 1 diabetes.
    BMJ. 2022;378:o1935.
    PubMed    
    
    
    July 2022
69. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    PubMed    
    
    
    June 2022
70. HE L, Wang J, Ping F, Yang N, et al
    Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
    BMJ. 2022;377:e068882.
    PubMed     Abstract available
    
    
    
71. WISE J
    Type 2 diabetes: Charity warns of "perfect storm" putting more children at risk.
    BMJ. 2022;377:o1451.
    PubMed    
    
    
    
72. WISE J
    Diabetes drug results in substantial weight loss in people with obesity, study finds.
    BMJ. 2022;377:o1406.
    PubMed    
    
    
    May 2022
73. 
    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1326.
    PubMed    
    
    
    
74. YE W, Luo C, Huang J, Li C, et al
    Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
    BMJ. 2022;377:e067946.
    PubMed     Abstract available
    
    
    
75. KAWAHARA T, Suzuki G, Mizuno S, Inazu T, et al
    Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.
    BMJ. 2022;377:e066222.
    PubMed     Abstract available
    
    
    
76. CHRISTIDES T
    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1166.
    PubMed    
    
    
    
77. RUSSELL EL
    Managing type 1 diabetes: have faith in patients.
    BMJ. 2022;377:o1240.
    PubMed    
    
    
    
78. ARMSTRONG GRAY T, Hussain S, Gray M
    Empower young people with type 1 diabetes.
    BMJ. 2022;377:o1237.
    PubMed    
    
    
    
79. MORAN GM, Bakhai C, Song SH, Agwu JC, et al
    Type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2022;377:o775.
    PubMed    
    
    
    April 2022
80. 
    SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2022;377:o1080.
    PubMed    
    
    
    
81. SAUL H, Gursul D, Cassidy S, Sharpe D, et al
    Why don't children and young people engage with diabetes services?
    BMJ. 2022;377:o750.
    PubMed     Abstract available
    
    
    
82. NG SM, Corbett T, Doble E, Brooks A, et al
    Managing the psychosocial impact of type 1 diabetes in young people.
    BMJ. 2022;377:e070530.
    PubMed    
    
    
    March 2022
83. IACOBUCCI G
    All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE.
    BMJ. 2022;376:o834.
    PubMed    
    
    
    
84. DYER C
    Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place.
    BMJ. 2022;376:o787.
    PubMed    
    
    
    
85. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    PubMed     Abstract available
    
    
    February 2022
86. MAHASE E
    Type 1 diabetes drug was withdrawn because of a "commercial conflict of interest," charity argues.
    BMJ. 2022;376:o373.
    PubMed    
    
    
    
87. TANNE JH
    Diabetes kills 100 000 Americans for second year in a row.
    BMJ. 2022;376:o300.
    PubMed    
    
    
    January 2022
88. MAHMOOD A, Dar S, Dabhad A, Aksi B, et al
    Advising patients with existing conditions about fasting during Ramadan.
    BMJ. 2022;376:e063613.
    PubMed    
    
    
    
89. 
    Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o109.
    PubMed    
    
    
    
90. JAYEDI A, Soltani S, Motlagh SZ, Emadi A, et al
    Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2022;376:e067516.
    PubMed     Abstract available
    
    
    
91. SLUGGETT JK, Rigby D
    Simplifying medications for people with type 2 diabetes.
    BMJ. 2022;376:n3158.
    PubMed    
    
    
    December 2021
92. GAHUNGU N, Trueick R, Coopes M, Gabbay E, et al
    Paroxysmal atrial fibrillation.
    BMJ. 2021;375:e058568.
    PubMed    
    
    
    
93. BESSER REJ, Ng SM, Robertson EJ
    Screening children for type 1 diabetes.
    BMJ. 2021;375:e067937.
    PubMed    
    
    
    November 2021
94. NOLAN T
    Tom Nolan's research reviews-26 November 2021.
    BMJ. 2021;375:n2938.
    PubMed    
    
    
    
95. AUBERT CE, Lega IC, Bourron O, Train AJ, et al
    When and how to deintensify type 2 diabetes care.
    BMJ. 2021;375:e066061.
    PubMed    
    
    
    October 2021
96. IACOBUCCI G
    One in 10 UK adults could have diabetes by 2030, warns charity.
    BMJ. 2021;375:n2453.
    PubMed    
    
    
    September 2021
97. SLIEKER RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, et al
    Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    BMJ. 2021;374:n2134.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.